Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Drug Saf

Department of Dermatology, University of Connecticut Health Center, 21 South Road, 2nd Floor, Farmington, CT, 06030, USA.

Published: June 2019

In the original publication of this article, the following correction should be noted in Table 5.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520476	PMC
http://dx.doi.org/10.1007/s40264-019-00816-3	DOI Listing

Publication Analysis

correction ustekinumab

ustekinumab safety

safety psoriasis

psoriasis psoriatic

psoriatic arthritis

arthritis crohn's

crohn's disease

disease integrated

integrated analysis

analysis phase

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!